Atezolizumab trials for Stage IV Lung Cancer AJCC v8
All Atezolizumab trials · All Stage IV Lung Cancer AJCC v8 trials
6
Recruiting trials
Phase breakdown
Phase 1 3Phase 2 5
Recruiting trials studying Atezolizumab for Stage IV Lung Cancer AJCC v8
- Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
- Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
- Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Common questions
How many trials study Atezolizumab for Stage IV Lung Cancer AJCC v8?
6 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.